Nature Communications. Scientists discover the immunomodulatory activity of a drug that would improve the efficacy of immunotherapy against breast cancer
The team of Eva González-Suarez, from the CNIO and IDIBELL, and the team of Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumours
These findings propose a new target to increase the antitumor immune response and make breast cancer more sensitive to immunotherapy